Behind every dataset, every model, and every regulatory decision lies one common objective: improving patient outcomes.
Join us for 2.5 days of high-level scientific exchange dedicated to the role of statistics across the CMC lifecycle — from raw data to quality, safety, efficacy, and regulatory confidence.
📊 Theme
From Data to Patients – CMC Statisticians’ Contributions to Quality, Safety, and Efficacy of Pharmaceutical Products
📅 October 20–22, 2026
📍 Rockville, Maryland, USA
This year’s program will bring together experts from industry, academia, and health authorities to explore key topics including:
🔹 Data strategy and quality
🔹 Statistical software in regulated environments
🔹 Methodological innovation: Frequentist, Bayesian, AI
🔹 Regulatory review and global expectations
Whether you are a statistician, scientist, regulator, or industry professional, this workshop is an opportunity to connect, learn, and help shape the future of pharmaceutical development.
📝 Register now: https://lnkd.in/dessJnZU
🔗 Learn more: https://lnkd.in/eKMCmYAQ
Let’s turn data into decisions — and decisions into better outcomes.
Ruojia Li, Jia Liu, José Ramírez, Timo Bailer, Catherine Cheng, Jennifer L Kirk, Irina Gershgorin, Ashley Giambrone, Cristian M. Oliva-Aviles, Oluyemi Oyeniran, Laura Pack, Jayda Siggers, Chris Thompson, Travis Wolter, Fang Fang Chen Chen, Brooke Marshall, JJ(Jie) Zhao
#IABS #StatisticsWorkshop #RegistrationOpen #Biostatistics #CMC #RegulatoryScience #DataScience #PharmaceuticalDevelopment #ClinicalResearch #PublicHealth